Bank of Montreal
LMNL

Bank of Montreal’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

Bank of Montreal’s Portfolio LMNL Stock Details LMNL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14
Closed -$1K – 5209
2021
Q1 		$1K Sell
14
-1
-7% -$49 ﹤0.01% 5021
2020
Q4 		$1K Hold
15
– – ﹤0.01% 4893
2020
Q3 		$1K Sell
15
-13
-46% -$1.76K ﹤0.01% 4727
2020
Q2 		$4K Hold
28
– – ﹤0.01% 4468
2020
Q1 		$2K Sell
28
-16
-36% -$1.44K ﹤0.01% 3908
2019
Q4 		$4K Buy
+44
New +$2.97K ﹤0.01% 4731

Other funds holding LMNL

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of Montreal's LMNL Position: Q2 2021 in Review

Bank of Montreal sold out of Liminal BioSciences Inc. Common Shares (LMNL) in Q2 2021, closing a stake of 14 shares — an estimated $1K sold.

Bank of Montreal first reported a position in LMNL in Q4 2019 and held it in 6 quarters. The position peaked at $4K in Q2 2020. 17 funds tracked by Wall St. Rank hold LMNL as of Q2 2021.

  • Bank of Montreal reported no remaining Liminal BioSciences Inc. Common Shares position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 14 Liminal BioSciences Inc. Common Shares shares in Q2 2021, an estimated $1K.
  • Bank of Montreal first reported a position in Liminal BioSciences Inc. Common Shares in Q4 2019 and held it in 6 quarters.
  • Bank of Montreal's Liminal BioSciences Inc. Common Shares position peaked at $4K in Q2 2020.
  • 17 funds tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.